- Page 2 and 3:
Guidelines for ATCvet classificatio
- Page 4 and 5:
Guidelines for ATCvet classificatio
- Page 6 and 7:
Preface The Anatomical Therapeutic
- Page 8 and 9:
Contents 1 Introduction to the ATCv
- Page 10:
QN - Nervous system................
- Page 13 and 14:
1.3 Relationship between the ATCvet
- Page 15 and 16:
Classification according to the mai
- Page 17 and 18:
2.2 Classification of plain prepara
- Page 19 and 20:
- Proposed ATCvet classification, w
- Page 22 and 23:
QA ALIMENTARY TRACT AND METABOLISM
- Page 24 and 25:
QA ALIMENTARY TRACT AND METABOLISM
- Page 26 and 27:
QA02B DRUGS FOR PEPTIC ULCER AND GA
- Page 28 and 29:
QA03D QA03DA QA03DB QA03DC ANTISPAS
- Page 30 and 31:
Combined packages comprising tablet
- Page 32 and 33:
QA07D QA07DA ANTIPROPULSIVES Antipr
- Page 34 and 35:
QA10BD QA10BF QA10BG QA10BH QA10BX
- Page 36 and 37:
QA11GB Ascorbic acid (vitamin C), c
- Page 38 and 39:
QA12CD QA12CE Fluoride Selenium Sod
- Page 40 and 41:
QB BLOOD AND BLOOD FORMING ORGANS Q
- Page 42 and 43:
QB02BC Local hemostatics Gauze, tam
- Page 44 and 45:
QB05C IRRIGATING SOLUTIONS Preparat
- Page 46 and 47:
QC CARDIOVASCULAR SYSTEM QC01 QC02
- Page 48 and 49:
QC CARDIOVASCULAR SYSTEM QC01 QC01A
- Page 50 and 51:
QC01D VASODILATORS USED IN CARDIAC
- Page 52 and 53:
QC02DC QC02DD QC02DG QC02K Pyrimidi
- Page 54 and 55:
QC03C HIGH-CEILING DIURETICS High-c
- Page 56 and 57:
QC05C QC05CA QC05CX CAPILLARY STABI
- Page 58 and 59:
QC08D QC08DA QC08DB SELECTIVE CALCI
- Page 60 and 61:
QD DERMATOLOGICALS QD01 QD02 QD03 Q
- Page 62 and 63:
QD DERMATOLOGICALS This main group
- Page 64 and 65:
QD02BB Protectives against UV-radia
- Page 66 and 67:
QD05BX Other drugs for keratoseborr
- Page 68 and 69:
QD07C CORTICOSTEROIDS, COMBINATIONS
- Page 70 and 71:
QD08AH Quinoline derivatives Chloro
- Page 72 and 73:
QG GENITO URINARY SYSTEM AND SEX HO
- Page 74 and 75:
QG01AA Antibiotics Combinations wit
- Page 76 and 77:
QG02CB QG02CC Prolactine inhibitors
- Page 78 and 79:
The group is subdivided according t
- Page 80 and 81:
QG04B OTHER UROLOGICALS, INCL. ANTI
- Page 82:
QG52 PRODUCTS FOR TEATS AND UDDER P
- Page 85 and 86:
QH SYSTEMIC HORMONAL PREPARATIONS,
- Page 87 and 88:
QH02 CORTICOSTEROIDS FOR SYSTEMIC U
- Page 89 and 90:
QH05B QH05BA ANTI-PARATHYROID AGENT
- Page 91 and 92:
QI09 QI10 QI11 Q120 IMMUNOLOGICALS
- Page 93 and 94:
QI01 QI01A QI01AA QI01AB QI01AC QI0
- Page 95 and 96:
QI01C QI01CA QI01CB QI01CC QI01CD Q
- Page 97 and 98:
QI01E QI01EA QI01EB QI01EC QI01ED Q
- Page 99 and 100:
QI01KV QI01KX Other inactivated vac
- Page 101 and 102:
QI03AM QI03AN QI03AO QI03AP QI03AQ
- Page 103 and 104:
QI05AH QI05AI QI05AJ Live and inact
- Page 105 and 106:
QI07 QI07A QI07AA QI07AB QI07AC QI0
- Page 107 and 108:
QI07X QI07XA QI07XB QI07XC QI07XD Q
- Page 109 and 110:
QI08B HARE QI08X LEPORIDAE, OTHERS
- Page 111 and 112:
QI10AR QI10AS QI10AU QI10AV QI10AX
- Page 113 and 114:
QI20AD QI20AE QI20AF QI20AG QI20AH
- Page 115 and 116:
QI20DD QI20DE QI20DF QI20DG QI20DH
- Page 117 and 118:
QJ ANTIINFECTIVES FOR SYSTEMIC USE
- Page 119 and 120:
QJ01D OTHER BETA-LACTAM ANTIBACTERI
- Page 121 and 122:
QJ01FG Streptogramins The streptogr
- Page 123 and 124:
QJ01XX Other antibacterials Fumagil
- Page 125 and 126:
QJ05AH Neuraminidase inhibitors All
- Page 127 and 128:
QJ51RB QJ51RC QJ51RD Amphenicols, c
- Page 129 and 130: QL ANTINEOPLASTIC AND IMMUNOMODULAT
- Page 131 and 132: QL02 ENDOCRINE THERAPY Only prepara
- Page 134 and 135: QM MUSCULO-SKELETAL SYSTEM QM01 QM0
- Page 136 and 137: QM01B QM01BA ANTIINFLAMMATORY/ANTIR
- Page 138 and 139: QM03BC Ethers, chemically close to
- Page 140 and 141: QN NERVOUS SYSTEM QN01 QN02 QN03 QN
- Page 142 and 143: QN01B ANESTHETICS, LOCAL Local anes
- Page 144 and 145: QN02AG Opioids in combination with
- Page 146 and 147: QN03AF QN03AG QN03AX Carboxamide de
- Page 148 and 149: QN05B ANXIOLYTICS Preparations used
- Page 150 and 151: Lithium, see QN05AN - Lithium. Comb
- Page 152: QN07C QN07CA ANTIVERTIGO PREPARATIO
- Page 155 and 156: QP ANTIPARASITIC PRODUCTS, INSECTIC
- Page 157 and 158: Optional subgroups should be used o
- Page 159 and 160: QP53BB Organophosphorous compounds
- Page 161 and 162: QR RESPIRATORY SYSTEM Preparations
- Page 163 and 164: QR03 QR03A DRUGS FOR OBSTRUCTIVE AI
- Page 165 and 166: Preparations which contain small am
- Page 167 and 168: QR06AE Piperazine derivatives Cinna
- Page 169 and 170: QS SENSORY ORGANS Preparations for
- Page 171 and 172: QS01E ANTIGLAUCOMA PREPARATIONS AND
- Page 173 and 174: QS01KA Viscoelastic substances Hyal
- Page 175 and 176: QS03 OPHTHALMOLOGICAL AND OTOLOGICA
- Page 177 and 178: QV VARIOUS This group is the most h
- Page 179: QV04CC Tests for bile duct patency
- Page 183 and 184: QV09A CENTRAL NERVOUS SYSTEM This g
- Page 185 and 186: QV09G CARDIOVASCULAR SYSTEM This gr
- Page 187 and 188: QV10X OTHER THERAPEUTIC RADIOPHARMA
- Page 190 and 191: WHO COLLABORATING CENTRE FOR DRUG S
- Page 192: ANNEX II
- Page 195: ORDER FORM - ATCvet PUBLICATIONS Pa